• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人肝癌/痘苗病毒系统中表达的具有生物活性的重组凝血酶原和抗凝血酶III。

Biologically active recombinant prothrombin and antithrombin III expressed in a human hepatoma/vaccinia virus system.

作者信息

Russo G, Mertens K, De Magistris L, Lange H, Cortese R, Pietropaolo C

机构信息

Dipartimento di Biochimica e Biotecnologie Mediche, II Facoltà di Medicina e Chirurgia, Università di Napoli Federico II, Italy.

出版信息

Biotechnol Appl Biochem. 1991 Oct;14(2):222-33.

PMID:1662049
Abstract

Several systems have been devised that are based on viral promoters suitable for gene expression in eukaryotic cells. One such system, vaccinia virus, has been successfully used to express a variety of heterologous proteins following the construction of a recombinant virus. Indeed, because of the ability of vaccinia virus to infect a wide range of host cells, the expression system can be custom-designed so that a cell line can be instrumental in ensuring the correct processing of the recombinant polypeptide. We show that recombinant vaccinia virus and human hepatoma cells in culture are an efficient expression system with which to produce correctly modified and biologically active human prothrombin (15 micrograms/10(7) cells) and antithrombin III (40 micrograms/10(7) cells).

摘要

已经设计出了几种基于适用于真核细胞基因表达的病毒启动子的系统。其中一种这样的系统,即痘苗病毒,在构建重组病毒后已成功用于表达多种异源蛋白质。实际上,由于痘苗病毒能够感染多种宿主细胞,因此可以对表达系统进行定制设计,以便细胞系有助于确保重组多肽的正确加工。我们表明,培养中的重组痘苗病毒和人肝癌细胞是一种高效的表达系统,可用于产生正确修饰且具有生物活性的人凝血酶原(15微克/10^7个细胞)和抗凝血酶III(40微克/10^7个细胞)。

相似文献

1
Biologically active recombinant prothrombin and antithrombin III expressed in a human hepatoma/vaccinia virus system.在人肝癌/痘苗病毒系统中表达的具有生物活性的重组凝血酶原和抗凝血酶III。
Biotechnol Appl Biochem. 1991 Oct;14(2):222-33.
2
High level expression of active human prothrombin in a vaccinia virus expression system.活性人凝血酶原在痘苗病毒表达系统中的高水平表达。
Thromb Haemost. 1992 Aug 3;68(2):119-24.
3
Transient and inducible expression of vaccinia/T7 recombinant viruses.痘苗病毒/T7重组病毒的瞬时和诱导表达
Methods Mol Biol. 2004;269:41-50. doi: 10.1385/1-59259-789-0:041.
4
Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteins.缺陷痘苗病毒作为一种用于过量生产重组人分泌蛋白的生物安全工具。
Protein Expr Purif. 1998 Dec;14(3):317-26. doi: 10.1006/prep.1998.0970.
5
Requirements for optimal expression of secreted and nonsecreted recombinant proteins in vaccinia virus systems.痘苗病毒系统中分泌型和非分泌型重组蛋白最佳表达的要求。
Protein Expr Purif. 1995 Oct;6(5):559-69. doi: 10.1006/prep.1995.1074.
6
High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara.使用安全病毒载体在哺乳动物细胞中实现高水平蛋白质表达:改良安卡拉痘苗病毒
Protein Expr Purif. 2007 Dec;56(2):269-78. doi: 10.1016/j.pep.2007.08.003. Epub 2007 Aug 24.
7
Vectors for recombinational cloning and gene expression in mammalian cells using modified vaccinia virus Ankara.利用改良安卡拉痘苗病毒在哺乳动物细胞中进行重组克隆和基因表达的载体。
Anal Biochem. 2010 Sep 1;404(1):103-5. doi: 10.1016/j.ab.2010.04.039. Epub 2010 May 5.
8
Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.标记基因交换通过宿主范围选择促进重组安卡拉痘苗病毒的生产。
J Virol Methods. 2009 Mar;156(1-2):37-43. doi: 10.1016/j.jviromet.2008.10.026. Epub 2008 Dec 10.
9
Recombinant swinepox virus expressing beta-galactosidase: investigation of viral host range and gene expression levels in cell culture.表达β-半乳糖苷酶的重组猪痘病毒:细胞培养中病毒宿主范围及基因表达水平的研究
Virology. 1998 Apr 10;243(2):396-405. doi: 10.1006/viro.1998.9053.
10
Recombinant vaccinia mucin vector: in vitro analysis of expression of tumor-associated epitopes for antibody and human cytotoxic T-cell recognition.重组痘苗粘蛋白载体:肿瘤相关表位表达的体外分析,用于抗体及人细胞毒性T细胞识别
J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):127-35.